Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Adaptimmune Therapeutics plc - American Depositary Shares
(NQ:
ADAP
)
0.5780
+0.0015 (+0.26%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Adaptimmune Therapeutics plc - American Depositary Shares
< Previous
1
2
3
4
Next >
Recap: Adaptimmune Therapeutics Q1 Earnings
May 12, 2023
Via
Benzinga
Earnings Preview For Adaptimmune Therapeutics
May 11, 2023
Via
Benzinga
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
April 11, 2023
The company bulks up its pipeline by regaining the rights to two of its clinical programs.
Via
The Motley Fool
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
March 07, 2023
Via
Benzinga
Why Is TCR2 Therapeutics Stock Trading Higher Today?
March 06, 2023
TCR² Therapeutics (NASDAQ: TCRR) shares are trading higher on Monday after the company and Adaptimmune Therapeutics (NASDAQ: ADAP) announced an agreement under which the two companies will combine to...
Via
Benzinga
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 06, 2023
Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch...
Via
Benzinga
Adaptimmune Agrees To Merge With Another Cell Therapy Focused Company
March 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 06, 2023
Via
Benzinga
Why Is TCR2 Therapeutics (TCRR) Stock Up 30% Today?
March 06, 2023
A new deal offers a lifeline for TCRR stock and a compatible investment for Adaptimmune. Both companies are targeting solid cancer tumors.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 06, 2023
Via
Benzinga
Adaptimmune Therapeutics's Earnings Outlook
March 03, 2023
Via
Benzinga
NXP Semiconductors, UBS Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
January 31, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Expert Ratings for Adaptimmune Therapeutics
January 05, 2023
Via
Benzinga
Why Adaptimmune Therapeutics Stock Is Glowing Green Today
November 08, 2022
Positive trial data is powering the biotech's stock higher today.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 30, 2022
Via
Benzinga
Credit Suisse, Autodesk And Other Big Losers From Wednesday
November 25, 2022
U.S. stocks closed higher on Wednesday, with the Nasdaq Composite gaining more than 100 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022
November 09, 2022
Upgrades
Via
Benzinga
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
November 09, 2022
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 08, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 25, 2022
Gainers DBV Technologies (NASDAQ:DBVT) stock increased by 18.7% to $1.9 during Tuesday's after-market session. The company's market cap stands at $356.7 million.
Via
Benzinga
GSK Transfers Cell Therapy Program Rights To Adaptimmune, Terminates Second Cell Therapy Pact In A Day
October 25, 2022
Via
Benzinga
Domino's Pizza To $385? Plus This Analyst Cuts Price Target On Adaptimmune Therapeutics By Around 79%
October 04, 2022
UBS cut the price target on Domino's Pizza, Inc. (NYSE: DPZ) from $430 to $385. Domino's shares rose 4% to $329.11 on Tuesday.
Via
Benzinga
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
Via
Benzinga
Adaptimmune's Cancer Candidate Shows 44% Response Rate In Pretreated Ovarian, Urothelial, Head & Neck Cancers
September 09, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 09, 2022
Via
Benzinga
Adaptimmune Therapeutics: Q2 Earnings Insights
August 04, 2022
Adaptimmune Therapeutics (NASDAQ:ADAP) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
69 Biggest Movers From Friday
June 06, 2022
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 03, 2022
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.